Two Alzheimer’s Trial Failures Reveal Clinical Challenges

This week delivered a sobering reminder that Alzheimer’s disease continues to defy even the most sophisticated scientific strategies. Within 24 hours, two major pharmaceutical players—Johnson & Johnson and Novo Nordisk—announced failures of…